The best indicator for AbbVie (ABBV)
We backtested 382 indicators across daily, weekly and hourly charts on real AbbVie (ABBV) history. Here's what actually worked — risk-adjusted over the full backtest, with costs, and checked out-of-sample.
Where AbbVie (ABBV) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Waddah Attar Explosion
On the weekly chart, this is the strongest risk-adjusted edge we found for AbbVie (ABBV) over ~13.8 years — trailing buy-and-hold by 13.3% CAGR.
AbbVie (ABBV) on the weekly chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 3 agree was the strongest confluence setup we found for AbbVie (ABBV) — trailing buy-and-hold by 13.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Waddah Attar Explosion ✓ | Weekly | 7.3% | 0.91 | -10.5% | 65.5% | 29 | -13.3% |
| 2 | Projection Bands ✓ | Weekly | 12.5% | 0.87 | -21.0% | 92.0% | 25 | -8.1% |
| 3 | Net Volume ✓ | Daily | 15.7% | 0.85 | -42.1% | 48.2% | 141 | -4.8% |
| 4 | Liquidity Flow Oscillator ✓ | Daily | 15.7% | 0.85 | -42.1% | 48.2% | 141 | -4.8% |
| 5 | Murrey Math Lines ✓ | Daily | 11.4% | 0.84 | -24.4% | 91.4% | 35 | -9.1% |
| 6 | Zero-Lag MACD ✓ | Daily | 14.1% | 0.83 | -32.3% | 57.7% | 300 | -6.4% |
| 7 | Projection Bands ✓ | Daily | 11.0% | 0.79 | -25.4% | 73.2% | 112 | -9.5% |
| 8 | Chande Forecast Osc. ✓ | Weekly | 13.8% | 0.79 | -45.1% | 56.9% | 72 | -6.9% |
| 9 | Derivative Oscillator ✓ | Daily | 9.4% | 0.78 | -19.5% | 47.8% | 232 | -11.1% |
| 10 | CMO (21) ✓ | Daily | 13.8% | 0.78 | -35.2% | 42.9% | 161 | -6.7% |
| 11 | Half Trend ✓ | Daily | 14.0% | 0.78 | -29.5% | 46.4% | 84 | -6.5% |
| 12 | KDJ ✓ | Weekly | 11.9% | 0.78 | -47.1% | 54.7% | 64 | -8.8% |
| 13 | HalfTrend ✓ | Daily | 13.9% | 0.77 | -29.5% | 46.4% | 84 | -6.6% |
| 14 | Stochastic (10,3) ✓ | Weekly | 12.6% | 0.77 | -36.5% | 52.9% | 87 | -8.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on AbbVie (ABBV)
17 of 571 tested setups beat buy-and-hold on AbbVie (ABBV) outright. Another 203 could get there with leverage they would survive — but 163 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| Zero-Lag MACD | 2 | 1.76× | 4.26× |
| Projection Bands | 2 | none needed | 9.33× |
| Chande-Kroll Stop (fast) | 1 | 1.64× | 5.11× |
| Woodie Pivots | 1 | 1.68× | 5.65× |
| Accumulation Swing Index | 1 | 1.78× | 5.65× |
| Swing Index | 1 | 1.78× | 5.65× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For AbbVie (ABBV), Waddah Attar Explosion on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when AbbVie’s signal flips
We track AbbVie daily. Its backtested best indicator, Waddah Attar Explosion (Weekly), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.